COVID-19 vaccines-The way forward
Allergy
.
2022 Jan;77(1):15-16.
doi: 10.1111/all.14995.
Authors
Ludger Klimek
1
,
Ioana Agache
2
,
Emer Cooke
3
,
Marek Jutel
4
5
,
Cezmi A Akdis
6
,
Robyn O'Hehir
7
8
Affiliations
1
Center for Rhinology and Allergology, Wiesbaden, Germany.
2
Faculty of Medicine, Transylvania University, Brasov, Romania.
3
European Medicines Agency, Amsterdam, Netherlands.
4
Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
5
All-MED Medical Research Institute, Wroclaw, Poland.
6
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
7
Department of Immunology and Pathology, Monash University, Melbourne, Vic., Australia.
8
Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash, Vic., Australia.
PMID:
34191300
PMCID:
PMC8441906
DOI:
10.1111/all.14995
No abstract available
Keywords:
COVID; SARS-CoV; virus.
Publication types
Editorial
MeSH terms
Antibodies, Viral
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2
Substances
Antibodies, Viral
COVID-19 Vaccines